Omicron: Skyrocketing Cases,
Significant Risks for the Unvaccinated
Dr Kevin Kavanagh from Health Watch USAsm discusses the risks
and severity of Omicron infections in the unvaccinated and those who are
not immune. Much of the rosy picture being painted regarding severity of
disease is because of inclusion of breakthrough infections and
reinfections that produce relatively mild disease. Two new drugs are
coming on the market, one from Pfizer, paxlovid, and the other from
Merck, molnupiravir. Both will probably not be widely available during
the Omicron surge and should not be viewed as a substitute for
vaccination. Only one monoclonal antibody, the one from GSK, is
effective against Omicron. Home testing is critical, but unfortunately,
the announced Federal Program is too little too late. Finally, you need
to upgrade your masks to N95s. Jack Pattie Show. Dec. 24, 2021.
In addition, please go to
https://healthconference.org and register for
our Sept. 14th, 2022 webinar. There is a large list of world renowned speakers
and the event is free.
|